Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms | 0.090 | 1.000 | 9 | 2011 | 2019 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms | 0.090 | 1.000 | 9 | 2011 | 2019 | |||||||
|
0.925 | 0.080 | 12 | 68808776 | intron variant | G/C | snv | 2.3E-02 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2012 | 2019 | |||||||
|
0.925 | 0.080 | 12 | 68808776 | intron variant | G/C | snv | 2.3E-02 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2012 | 2019 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.040 | 1.000 | 4 | 2014 | 2018 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.040 | 1.000 | 4 | 2014 | 2018 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2011 | 2014 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms | 0.030 | 1.000 | 3 | 2015 | 2019 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Digestive System Diseases; Neoplasms | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms | 0.020 | < 0.001 | 2 | 2014 | 2016 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms | 0.020 | < 0.001 | 2 | 2014 | 2016 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms | 0.020 | < 0.001 | 2 | 2014 | 2016 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2008 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2018 | 2020 | |||||||
|
0.605 | 0.640 | 12 | 68808800 | intron variant | T/G | snv | 0.31 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 12 | 68808776 | intron variant | G/C | snv | 2.3E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.080 | 12 | 68808776 | intron variant | G/C | snv | 2.3E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 |